The U.S. Food and Drug Administration approved Gadavist (gadobutrol), a gadolinium-based contrast agent, for use in patients undergoing magnetic resonance imaging (MRI) of the central nervous system. Gadavist was approved by the…
Study Helps Explain How Pathogenic E. coli Bacterium Causes Illness
Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have shown how the O157:H7 strain of Escherichia coli causes infection and thrives by…
Refractory Angina Cell Therapy Protocol (ReACT(R)) Is Evaluated In An International Symposium
Cellpraxis (Brazil), USF Health (USA) and UNIFESP (Brazil) presented and evaluated the clinical results of an innovative therapy for Refractory Angina patients (ReACT) in a scientific meeting and workshop in São Paulo,…
Malaria Drug Slows Pancreatic Cancer Growth In Mouse Models
Dana-Farber Cancer Institute scientists report they have shrunk or slowed the growth of notoriously resistant pancreatic tumors in mice, using a drug routinely prescribed for malaria and rheumatoid arthritis. The pre-clinical results,…
New Treatment Options Lead To Steady Progress Against Ovarian Cancer; Clinical Trials Remain Imperative
Although finding effective screening tools remains a priority, new treatment options for women with ovarian cancer, such as the ones outlined in the updated NCCN Guidelines for Ovarian Cancer, are vital to…
Active Surveillance Monitoring More Stringent In Updated NCCN Guidelines For Prostate Cancer
Active surveillance or immediate treatment? The question that many men with prostate cancer and their clinicians struggle with continues to be a focus in the updated NCCN Guidelines™ for Prostate Cancer. James…
Purdue Research May Lead To Therapy That Delays Onset, Reduces Severity Of MS Symptoms
People suffering from multiple sclerosis may benefit if patent-pending research conducted at Purdue University shows that a decades-old drug approved by the FDA to treat hypertension also delays the onset and reduces…
NCCN Panel Calls For Higher Standards, Better Ways Of Translating Molecular Genetics Into Clinical Practice
In recent years, an increasing number of tests that use molecular genetics to assess the potential efficacy of cancer therapies in individual patients have become available. The introduction of these new tests…
Protein folding may aid in development of new therapies for brain diseases
Misfold an origami swan and the worst that happens is you wind up with an ugly paper duckling. Misfold one of the vital proteins in your body – each of which must…
March of Dimes to honor fragile X syndrome researcher with Lifetime Achievement award
A world-renowned fragile X syndrome researcher, who was the first to identify the long-sought genetic abnormality responsible for this disorder, will be honored by the March of Dimes. Stephen T. Warren, PhD,…
Psychological disorders may be more prevalent in adolescent acne patients
America’s prom season is on the horizon and with it comes distress for thousands of teens who will be distraught to see a pimple raise its ugly head on their nose or…
Discovery of molecular switch for the secretion of insulin
Johns Hopkins researchers believe they have uncovered the molecular switch for the secretion of insulin — the hormone that regulates blood sugar — providing for the first time an explanation of this…
Post-stroke depression management can lead to better physical functioning
Stroke patients who are not successfully treated for depression are at higher risk of losing some of their capability to function normally, according to a study in the March 15, 2011 issue…
Manchester research offers hope for congenital hyperinsulinism treatment
University of Manchester scientists have led an international team to discover new treatments for a rare and potentially lethal childhood disease that is the clinical opposite of diabetes mellitus. Congenital hyperinsulinism (CHI)…
Classifying gambling subtypes does not predict treatment outcomes
Approximately two million adults in the United States meet criteria for pathological gambling, and another four to six million are considered problem gamblers, according to the National Council on Problem Gambling. A…